The drug Immunex was produced by the company Amgen .
In November 1998 , Immunex , a future aquisition of Amgen , received approval for Enbrel ( etanercept ) , the first rheumatoid arthritis drug targeting tumor necrosis factor alpha ( TNF-alpha ) .
Amgen